<?xml version="1.0" encoding="UTF-8"?>
<ref id="B5-antioxidants-09-01083">
 <label>5.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mufson</surname>
    <given-names>E.J.</given-names>
   </name>
   <name>
    <surname>Counts</surname>
    <given-names>S.E.</given-names>
   </name>
   <name>
    <surname>Perez</surname>
    <given-names>S.E.</given-names>
   </name>
   <name>
    <surname>Ginsberg</surname>
    <given-names>S.D.</given-names>
   </name>
  </person-group>
  <article-title>Cholinergic system during the progression of Alzheimerâ€™s disease: Therapeutic implications</article-title>
  <source>Expert Rev. Neurother.</source>
  <year>2008</year>
  <volume>8</volume>
  <fpage>1703</fpage>
  <lpage>1718</lpage>
  <pub-id pub-id-type="doi">10.1586/14737175.8.11.1703</pub-id>
  <?supplied-pmid 18986241?>
  <pub-id pub-id-type="pmid">18986241</pub-id>
 </element-citation>
</ref>
